Skip to content

Reproducibility of RNFL and ONH Measurements in OAG With Heidelberg Spectralis SD-OCT Glaucoma Module Premium Edition

Study to Investigate Reproducibility of the New Heidelberg Spectralis SD-OCT Glaucoma Module Premium Edition (Software Version 6.0) in Comparison to Reproducibility of RNFL Scans.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02247284
Enrollment
50
Registered
2014-09-25
Start date
2015-03-01
Completion date
2019-12-31
Last updated
2020-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Open Angle Glaucoma

Brief summary

The purpose of this study is to assess and compare the repeatability of SD-OCT (Spectralis™ OCT, Version 6.0, Heidelberg Engineering, Germany) RNFL thickness measurements with a new software (glaucoma premium module) with the well established peripapillary RNFL thickness measurements in patients with primary open angle glaucoma.

Detailed description

The purpose of this study is to assess and compare the repeatability of SD-OCT (Spectralis™ OCT, Version 6.0, Heidelberg Engineering, Germany) RNFL thickness measurements with the new software (method B) and with the previous method of measurement (method A) in patients with glaucoma. It is a prospective, not blinded, not randomised, monocentric study. Inclusion of 50 patients with a diagnosis of primary open angle glaucoma (POAG), that will be recruited from the ophthalmology outpatient department of the UniversityHospital Zurich, Switzerland. All patients will undergo a full ophthalmic examination including measurement of refraction, best corrected visual acuity, examination of anterior and posterior compartment and measurement of the intraocular pressure. On the same day they will have 3 OCT examinations with a new method of measurement (method B).On the same day the first 10 patients will undergo also 3 OCT examinations with the previous method (method A) and they will get an other 3 OCT examinations with method B by a second observer. For this 10 patients the next consultation (3 months +/- 1 month) the 3 OCT examinations with method B will be repeated by the first observer. Primary objectives are coefficient of variations (COV) of method A and B; Intra-class-correlations (ICC) of method A and B.

Interventions

DEVICERNFL and BMO-MRW SD-OCT

Masurement of peripapillary RNFL measurements with Heidelberg Spectralis SD-OCT (Heidelberg Engeneering GmbH, Heidelberg, Germany) old protocoll and in addition with the new Glaucoma Premium Module (software version 6.0) tocoll, which in addition to RNFL measurements include measurement of Bruch's Membrane Opening-based minimum rim width (BMO-MRW).

Sponsors

University of Zurich
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* diagnosis of POAG glaucoma * male and female patients aged 18 years or older, no upper limit * written informed consent * visual acuity of more or equal to 0.5 Snellen * refractive error between + /- 6.00 D spheric and under or equal than 2.00 D cylindrical

Exclusion criteria

* history of surgery other than uncomplicated cataract surgery * disease affecting cornea, anterior compartment, lens, vitreous body * history of severe ocular disease, particularly diseases affecting the optic nerve, other than glaucoma * history of ocular trauma

Design outcomes

Primary

MeasureTime frameDescription
Retinal nerve fiber layer thickness (RNFL)baseline and 3 months +/- 1 monthRetinal nerve fiber layer thickness (RNFL) measured with Spectralis OCT
Bruch's membrane opening-based minimum rim width (BMO-MRW)baseline and 3 months +/- 1 monthBruch's membrane opening-based minimum rim width (BMO-MRW) measured with Spectralis OCT

Secondary

MeasureTime frameDescription
Coefficient of variations (COV) of RNFL and BMO-MRWbaseline and 3 months +/- 1 monthCoefficient of variations (COV) of RNFL and BMO-MRW
Intra-class-correlations (ICC) of RNFL and BMO-MRWbaseline and 3 months +/- 1 monthIntra-class-correlations (ICC) of RNFL and BMO-MRW

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026